| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11018177 | Urologic Oncology: Seminars and Original Investigations | 2018 | 8 Pages |
Abstract
Pre-treatment mpMRI findings are strongly associated with biochemical outcomes in a modern cohort of intermediate and high-risk patients treated with primary radiotherapy. mpMRI may aid risk stratification beyond clinical risk factors in men treated with radiation therapy; further study is warranted to better understand how mpMRI can be used to individualize therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Greg M.D., Fauzia M.B.B.S., Pritesh M.D., Aytek M.D., Stanley L. M.D.,